NAFDAC Seeks Effective Collaboration On Drug Regulation
NAFDAC Director General, Dr Paul Orhii, who made the call at the second NAFDAC Regulatory Forum in Lagos, said effective regulation was key to ensuring access to safe and quality health products in Nigeria.
Reeling out the benefits of effective collaboration, Orhii said adopting such approach would bring about increased regulatory capacity, improved regulatory infrastructure, private sector participation, confidence in the system and also strengthen the regulatory processes.
Orhii added that the essence of control and regulation was to protect the public’s health by ensuring that only quality-regulated products that are safe and wholesome get to them.
Director, Registration and Regulatory Affairs of NAFDAC, Dr. Monica Hemben Eimunjeze, stated that collaboration among stakeholder holds the key in sanitising the regulatory sector. “We strongly believe that collaboration is a key element to ensure success in regulation and remain resolute in our commitment to build stronger local, regional and international networks.
“Our collaborative efforts have resulted in considerable gains in our regulatory capacity both in terms of human capacity development and infrastructure. This has also impacted on the regulated sector with notable and remarkable achievements being made in the pharmaceutical industry as a result of positive engagements between NAFDAC, World Heath Organization (WHO) and the USP, to mention a few,” she said.
Also, Chairman, Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria, (PMG-MAN), Mr. Okey Akpa, said if the industry must grow, effective collaboration must be accorded priority.
No comments yet